Unaudited Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2022	$ 320,740	$ 42	$ 432,703	$ (1,535)	$ (110,470)
Beginning balance (in shares) at Dec. 31, 2022		41,616,260
Issuance of common stock and pre-funded common stock warrants, net of issuance costs	56,530	$ 4	56,526
Issuance of common stock and pre-funded common stock warrants, net of issuance costs (in shares)		4,153,717
Exercise of pre-funded common stock warrants (in shares)		80,257
Exercise of common stock options	1,659		1,659
Exercise of common stock options (in shares)		191,879
Shares issued under employee stock purchase plan	528		528
Shares issued under employee stock purchase plan (in shares)		57,911
Vesting of restricted shares	144		144
Vesting of restricted shares (in shares)		51,403
Stock-based compensation	15,522		15,522
Unrealized gain (loss) on available-for-sale securities, net	360			360
Net loss	(46,535)				(46,535)
Ending balance at Sep. 30, 2023	348,948	$ 46	507,082	(1,175)	(157,005)
Ending balance (in shares) at Sep. 30, 2023		46,151,427
Beginning balance at Jun. 30, 2023	299,469	$ 42	445,924	(1,060)	(145,437)
Beginning balance (in shares) at Jun. 30, 2023		41,867,536
Issuance of common stock and pre-funded common stock warrants, net of issuance costs	56,530	$ 4	56,526
Issuance of common stock and pre-funded common stock warrants, net of issuance costs (in shares)		4,153,717
Exercise of pre-funded common stock warrants (in shares)		80,257
Exercise of common stock options	79		79
Exercise of common stock options (in shares)		43,230
Vesting of restricted shares	5		5
Vesting of restricted shares (in shares)		6,687
Stock-based compensation	4,548		4,548
Unrealized gain (loss) on available-for-sale securities, net	(115)			(115)
Net loss	(11,568)				(11,568)
Ending balance at Sep. 30, 2023	348,948	$ 46	507,082	(1,175)	(157,005)
Ending balance (in shares) at Sep. 30, 2023		46,151,427
Beginning balance at Dec. 31, 2023	344,349	$ 46	512,401	665	(168,763)
Beginning balance (in shares) at Dec. 31, 2023		46,252,440
Issuance of common stock and pre-funded common stock warrants, net of issuance costs	320,059	$ 5	320,054
Issuance of common stock and pre-funded common stock warrants, net of issuance costs (in shares)		5,397,301
Exercise of common stock options	$ 6,053	$ 1	6,052
Exercise of common stock options (in shares)	613,132	613,132
Issuance of common stock upon vesting of restricted stock units (in shares)		2,500
Shares issued under employee stock purchase plan	$ 473		473
Shares issued under employee stock purchase plan (in shares)		63,070
Vesting of restricted shares	13		13
Vesting of restricted shares (in shares)		8,796
Stock-based compensation	26,769		26,769
Unrealized gain (loss) on available-for-sale securities, net	7,166			7,166
Net loss	(48,778)				(48,778)
Ending balance at Sep. 30, 2024	656,104	$ 52	865,762	7,831	(217,541)
Ending balance (in shares) at Sep. 30, 2024		52,337,239
Beginning balance at Jun. 30, 2024	657,677	$ 52	848,723	(1,616)	(189,482)
Beginning balance (in shares) at Jun. 30, 2024		52,162,215
Exercise of common stock options	1,649		1,649
Exercise of common stock options (in shares)		171,764
Issuance of common stock upon vesting of restricted stock units (in shares)		2,500
Vesting of restricted shares	3		3
Vesting of restricted shares (in shares)		760
Stock-based compensation	15,387		15,387
Unrealized gain (loss) on available-for-sale securities, net	9,447			9,447
Net loss	(28,059)				(28,059)
Ending balance at Sep. 30, 2024	$ 656,104	$ 52	$ 865,762	$ 7,831	$ (217,541)
Ending balance (in shares) at Sep. 30, 2024		52,337,239